Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease

Published:2021-07-01 Issue:7 Volume:6 Page:753
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Mayer Katharina¹,Hein-Rothweiler Ralph²,Schüpke Stefanie¹³,Janisch Marion¹,Bernlochner Isabell³⁴,Ndrepepa Gjin¹,Sibbing Dirk²³⁵,Gori Tommaso⁶⁷,Borst Oliver⁸,Holdenrieder Stefan⁹,Kupka Danny²,Petzold Tobias²,Bradaric Christian⁴,Okrojek Rainer⁴,Leistner David M.¹⁰¹¹,Trippel Tobias D.¹¹¹²,Münzel Thomas⁶⁷,Landmesser Ulf¹⁰¹¹,Pieske Burkert¹¹¹²,Zeiher Andreas M.⁷¹³,Gawaz Meinrad P.⁸,Hapfelmeier Alexander¹⁴¹⁵,Laugwitz Karl-Ludwig³⁴,Schunkert Heribert¹³,Kastrati Adnan¹³,Massberg Steffen²³

Affiliation:

1. Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany

2. Department of Cardiology, Medizinische Klinik und Poliklinik I, Munich University Clinic, Ludwig-Maximilian University of Munich, Munich, Germany

3. German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany

4. Medizinische Klinik und Poliklinik Innere Medizin I, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany

5. Privatklinik Lauterbacher Mühle am Ostersee, Iffeldorf, Germany

6. Department of Cardiology, University Medical Center Mainz, Mainz, Germany

7. German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Germany

8. Medizinische Klinik III–Kardiologie und Angiologie, Eberhard Karls University of Tübingen, Tübingen, Germany

9. Institut für Laboratoriumsmedizin, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany

10. Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Klinik für Kardiologie, Berlin, Germany

11. German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany

12. Charité-Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Kardiologie, Campus Virchow-Klinikum, Department of Internal Medicine and Cardiology, German Heart Center, Berlin, Germany

13. Cardiology Division, Department of Medicine III, Johann Wolfgang Goethe University, Frankfurt, Germany

14. Institute of Medical Informatics, Statistics and Epidemiology, Technical University of Munich School of Medicine, Munich, Germany

15. Institute of General Practice and Health Services Research, Technical University of Munich School of Medicine, Munich, Germany

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2777812/jamacardiology_mayer_2021_oi_210010_1625699344.42446.pdf

Reference35 articles.

1. Basic principles of platelet biology and clinical implications.;Angiolillo;Circ J,2010

2. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention.;Sibbing;JACC Cardiovasc Interv,2019